What is Sutro Biopharma's net change in cash?

Sutro Biopharma (STRO) reported net change in cash of $15.55M in Q1 2026.

How has Sutro Biopharma's net change in cash changed year-over-year?

Sutro Biopharma's net change in cash increased by 118.5% year-over-year, from -$84.08M to $15.55M.

What is the long-term trend for Sutro Biopharma's net change in cash?

Over 2 years (2021 to 2025), Sutro Biopharma's net change in cash has grown at a -12.8% compound annual growth rate (CAGR), from -$176.31M to -$134.08M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Sutro Biopharma STRO Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Gilead SciencesGILD

$65M+103%

RegenxbioRGNX

-$19.24M-127%

Nuvectis Pharma, Inc.NVCT

-$6.5M-157%

XencorXNCR

-$40M-2,970%

AnaptysBio, Inc.ANAB

$10.27M+142%

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Reported directly by Sutro Biopharma in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's net change in cash?: Sutro Biopharma (STRO) reported net change in cash of $15.55M in Q1 2026.
How has Sutro Biopharma's net change in cash changed year-over-year?: Sutro Biopharma's net change in cash increased by 118.5% year-over-year, from -$84.08M to $15.55M.
What is the long-term trend for Sutro Biopharma's net change in cash?: Over 2 years (2021 to 2025), Sutro Biopharma's net change in cash has grown at a -12.8% compound annual growth rate (CAGR), from -$176.31M to -$134.08M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.